<VariationArchive VariationID="17919" VariationName="NC_000011.10:g.(?_116800700)_(116841000_?)del" VariationType="Deletion" Accession="VCV000017919" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-27" DateCreated="2013-04-04" MostRecentSubmission="2024-05-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="32958" VariationID="17919">
      <GeneList>
        <Gene Symbol="APOA1" FullName="apolipoprotein A1" GeneID="335" HGNC_ID="HGNC:600" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="116835751" stop="116837950" display_start="116835751" display_stop="116837950" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="116706468" stop="116708337" display_start="116706468" display_stop="116708337" Strand="-" />
          </Location>
          <OMIM>107680</OMIM>
        </Gene>
        <Gene Symbol="APOA1-AS" FullName="APOA1 antisense RNA" GeneID="104326055" HGNC_ID="HGNC:40079" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="116836117" stop="116855729" display_start="116836117" display_stop="116855729" Strand="+" />
          </Location>
          <OMIM>620112</OMIM>
        </Gene>
        <Gene Symbol="APOA4" FullName="apolipoprotein A4" GeneID="337" HGNC_ID="HGNC:602" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="116820700" stop="116823304" display_start="116820700" display_stop="116823304" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="116691417" stop="116694010" display_start="116691417" display_stop="116694010" Strand="-" />
          </Location>
          <OMIM>107690</OMIM>
        </Gene>
        <Gene Symbol="APOC3" FullName="apolipoprotein C3" GeneID="345" HGNC_ID="HGNC:610" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="116829907" stop="116833072" display_start="116829907" display_stop="116833072" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="116700623" stop="116703786" display_start="116700623" display_stop="116703786" Strand="+" />
          </Location>
          <OMIM>107720</OMIM>
        </Gene>
        <Gene Symbol="LOC111718489" FullName="skeletal muscle cis-regulatory module in APOA4 and APOC3 intergenic region" GeneID="111718489" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="116825292" stop="116825807" display_start="116825292" display_stop="116825807" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000011.10:g.(?_116800700)_(116841000_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" innerStart="116800700" innerStop="116841000" display_start="116800700" display_stop="116841000" variantLength="40301" />
      </Location>
      <OtherNameList>
        <Name>APOA1, DEL</Name>
        <Name>DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.(?_116800700)_(116841000_?)del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.(?_116800700)_(116841000_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="107680.0012" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS for allelic variant 107680.0012 from the description in the paper by Ordovas et al., 1989 (PubMed 2506176) that the deletion began about 3.1 kb upstream of APOA1 and extended about 20 kb downstream of APOA4.  The sequence across the breakpoint in Figure 1 was not confirmed.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000011.10:g.(?_116800700)_(116841000_?)del AND Apolipoprotein A-I deficiency" Accession="RCV000019512" Version="24">
        <ClassifiedConditionList TraitSetID="5958">
          <ClassifiedCondition DB="MedGen" ID="C0342898">Apolipoprotein A-I deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1989-10-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1989-10-05" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2024-05-26">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">2506176</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">6800349</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5958" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="12962" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Apolipoprotein A-I deficiency</ElementValue>
                <XRef ID="MONDO:0100189" DB="MONDO" />
              </Name>
              <XRef ID="425" DB="Orphanet" />
              <XRef ID="C0342898" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="39809" SubmissionDate="2012-08-03" DateLastUpdated="2024-05-26" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="107680.0012_APOLIPOPROTEIN A-I, ABSENCE OF, DUE TO DELETION OF APOA1/APOC3/APOA4 GENE COMPLEX" title="APOA1, DEL_APOLIPOPROTEIN A-I, ABSENCE OF, DUE TO DELETION OF APOA1/APOC3/APOA4 GENE COMPLEX" />
        <ClinVarAccession Accession="SCV000039809" DateUpdated="2024-05-26" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1989-10-05">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Schaefer et al. (1982) studied the plasma lipids of a middle-aged woman who died following coronary artery bypass grafting for atherosclerotic narrowing of multiple arteries. She had markedly reduced high density lipoprotein, no detectable apolipoprotein A-I, normal A-II, and moderately reduced apolipoproteins B and C (see 620058). Both of her children, all 6 of her living sibs, and both parents had reduced apolipoprotein A-I and HDL levels and normal apolipoprotein A-II. Three of the sibs and their mother had coronary disease. The proband had corneal clouding due to diffuse lipid deposits in the epithelial cells; none of the heterozygotes had this finding. The condition in this family differs from Tangier disease (205400; analphalipoproteinemia) in the complete absence of apolipoprotein A-I and normal levels of A-II in the homozygote. Heterozygotes in this condition have reduced A-I only, whereas Tangier heterozygotes have reduced A-I and A-II. Consanguinity in this family, while likely on the basis of geographic isolation, was not proved. In the family reported by Schaefer et al. (1982), Ordovas et al. (1989) demonstrated that all of the APOA1/APOC3/APOA4 gene complex was deleted from a point about 3.1 kb 5-prime to the APOA1 gene to a point 3-prime to the APOA4 gene.</Attribute>
              <Citation>
                <ID Source="PubMed">6800349</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">2506176</ID>
              </Citation>
              <XRef DB="OMIM" ID="620058" Type="MIM" />
              <XRef DB="OMIM" ID="205400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOA1" />
          </GeneList>
          <Name>APOA1, DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="107680.0012" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">APOLIPOPROTEIN A-I, ABSENCE OF, DUE TO DELETION OF APOA1/APOC3/APOA4 GENE COMPLEX</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="39809" TraitType="Disease" MappingType="Name" MappingValue="APOLIPOPROTEIN A-I, ABSENCE OF, DUE TO DELETION OF APOA1/APOC3/APOA4 GENE COMPLEX" MappingRef="Preferred">
        <MedGen CUI="C0342898" Name="Apolipoprotein A-I deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

